Brain Hemorrhage is a type of stroke. It's caused by an artery in the brain bursting and causes localized bleeding in the surrounding tissues. This bleeding is likely to kill brain cells. There are several risk factors and causes of brain hemorrhages such as head trauma, high blood pressure, blood vessel abnormalities, aneurysms, brain tumors, and blood tumors.
This report contains market size and forecasts of Brain Hemorrhage Treatment in Global, including the following market information:
Global Brain Hemorrhage Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Brain Hemorrhage Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-hypertensive Medicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brain Hemorrhage Treatment include Bayer, Boehringer Ingelheim, Johnson and Johnson, Novo Nordisk, Bristol-Myers Squibb, H. Lundbeck, Oxurion, Ligand Pharmaceuticals and Neurotec Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Hemorrhage Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Hemorrhage Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Brain Hemorrhage Treatment Market Segment Percentages, by Type, 2021 (%)
Anti-hypertensive Medicine
Anti-anxiety Medicine
Hyperosmotic Medicine
Anti-seizure Medicine
Global Brain Hemorrhage Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Brain Hemorrhage Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Other
Global Brain Hemorrhage Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Brain Hemorrhage Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Hemorrhage Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Brain Hemorrhage Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Boehringer Ingelheim
Johnson and Johnson
Novo Nordisk
Bristol-Myers Squibb
H. Lundbeck
Oxurion
Ligand Pharmaceuticals
Neurotec Pharma